McDermott Will & Emery Represents H.I.G. Capital in Cross-Border Sale of Its Life Sciences Portfolio Company BIOVECTRA
September 26, 2024
September 26, 2024
CHICAGO, Illinois, Sept. 26 -- McDermott Will and Emery, a law firm, issued the following news release:
International law firm McDermott Will & Emery represented H.I.G. Capital, LLC (H.I.G.), a leading global alternative investment firm with $65 billion of capital under management, in the sale of its portfolio company, BIOVECTRA Inc. (BIOVECTRA) to Agilent Technologies, Inc.
BIOVECTRA is a Canada-based contract development and manufacturing organization for key ingr . . .
International law firm McDermott Will & Emery represented H.I.G. Capital, LLC (H.I.G.), a leading global alternative investment firm with $65 billion of capital under management, in the sale of its portfolio company, BIOVECTRA Inc. (BIOVECTRA) to Agilent Technologies, Inc.
BIOVECTRA is a Canada-based contract development and manufacturing organization for key ingr . . .